Indeed, our results showed that PD-L1 positive cases have worse RFS than PD-L1 negative cases in EGFR-mutated lung adenocarcinoma, but not in EGFR-wildtype lung adenocarcinoma (Figures 3B, C). The gene discussed is EGFR; the disease is lung adenocarcinoma.